Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 86

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 86
---
 which the NLS Meeting will not resolve on such an agenda item). Therefore, should you fail to take any action in connection with the NLS Meeting, the resolutions adopted at the NLS Meeting will be effective in relation to you. It does not restrict your right to challenge or declare void any resolutions adopted by the NLS Meeting. Q.What if I return a proxy card or otherwise vote but do not make specific choices? If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable: •“FOR” Proposal No. 1 to approve the Merger Agreement. •“FOR” Proposal No. 2 to approve the par value reduction, reverse split and ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •“FOR” Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of preferred shares. •“FOR” Proposal No. 4 to approve the reinstatement of the capital band. •“FOR” Proposal No. 5 to approve the conditional share capital for employee and advisory options. •“FOR” Proposal No. 6 to approve the conditional share capital for shareholders’ options. •“FOR” Proposal No. 7 to approve the transfer and voting rights limitation of 9.99%. •“FOR” Proposal No. 8 to approve the name change of NLS. •“FOR” Proposal No. 9 to approve the election of the new members to the NLS Board. •“FOR” Proposal No. 10 to approve the election of members of the Compensation, Nomination and Governance Committee. •“FOR” Proposal No. 11 to approve the composition of the new senior management following the Merger. •“FOR” Proposal No. 12.1 to approve the compensation for the members of the NLS Board. •“FOR” Proposal No. 12.2 to approve the compensation for the executive officers. •“FOR” Proposal No. 13 to approve the CVR Agreement. •“FOR” Proposal No. 14 to approve the conversion of outstanding options and RSUs issued by Kadimastem. Q.What should I do if I receive more than one set of voting materials? With regard to the NLS Meeting, shareholders of NLS which receive more than one set of voting materials are asked to inform NLS and return all redundant voting materials to NLS by mail (NLS Pharmaceutics Ltd., Alexander Zwyer